VIVE — Viveve Medical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.28m
- $6.43m
Viveve Medical Inc expected to post a loss of 61 cents a share - Earnings Preview
Brief: Viveve Medical Announces Issuance Of New Method Patent For Stress Urinary Incontinence In Australia
Brief: Viveve Medical Q2 Revenue $1.7 Million
Viveve Medical Inc reports results for the quarter ended in June - Earnings Summary
Viveve Medical Inc expected to post a loss of 65 cents a share - Earnings Preview
Brief: Viveve Medical Files For Mixed Shelf Of Up To $75 Million
Viveve Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Viveve Medical Posts Quarterly Loss Per Share Of $0.80
Viveve Medical Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Viveve Medical Files Prospectus Related To Resale Of Up To 3.5 Million Shares By Lincoln Park Capital Fund
Brief: Viveve Medical Inc Says On March 31 Co, Lincoln Park Capital Fund Entered Into First Amendment To Purchase Agreement
Brief: Viveve Medical Says Co Has Capital Resources To Support Operations Through Year-End 2022
Brief: Viveve Medical Announces Expansion Of IP Portfolio With Issuance Of S. Korean Patent
U.S. STOCKS ON THE MOVE-Alaska Air, Acacia Communications, Gilead Sciences Inc, Apache Corp
U.S. STOCKS ON THE MOVE-Lemonade, Beyond Meat, Super League Gaming, Express Inc
U.S. STOCKS ON THE MOVE-China tech giants, NantKwest, Chembio Diagnostics, Delta Air Lines
Brief: Viveve Medical says Proposed Changes To Study Design Of Pivotal Pursuit Trial Approved By U.S. FDA
Viveve: Up as FDA approves changes to study design for urine leakage treatment
-Viveve Medical: Jumps after FDA clearance for manufacturing expansion